Accrued Expenses and Other Current Liabilities

3 Months Ended

Mar. 31, 2020

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

Accrued Expenses and Other Current Liabilities

Accrued expenses consisted of the following:

	As of March 31, 2020		As of December 31, 2019
Accrued development milestones	$	32,801	$	12,000
Accrued employee compensation and benefits	9,462		3,521
Accrued clinical trial costs	9,736		16,476
Accrued commercialization and other professional fees	17,864		15,408
Other accrued expenses and current liabilities	6,907		4,697
	$	76,770	$	52,102